Cost

In most cases, because there are not a lot of sites, patients and data to collect and manage, it simply doesn’t make sense to spend voluminous amounts of money when paper can do the trick for these smaller trials. With OmniComm’s low, fixed-pricing for Phase I studies, the cost of EDC can still be less than that of the cost of running traditional paper-based trials. TrialMaster’s mid-study analysis capabilities also allow companies to make earlier and more informed decisions on the viability of the study, resulting in significant cost avoidance.

[ Back to TrialMaster Ph. I ]